BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

Clover Health (CLOV)Clover HealthConference / presentation

WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Canaccord Genuity 46th Annual Growth Conference on

Related news

CLOVClover Health2026-02-17 21:05 EST

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference

CLOVClover Health2026-07-09 20:05 EST

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-08-05 20:05 EST

Clover Health Reports Second Quarter 2026 Results

CLOVClover Health2026-07-22 20:05 EST

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

CLOVClover Health2026-07-09 20:05 EST

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026

CLOVClover Health2026-07-07 12:30 EST

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

CLOVClover Health2026-05-06 20:05 EST

Clover Health Reports First Quarter 2026 Results

Stock data

Close
4.66 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States